title: Haploidentical haematopoietic stem cell transplantation using CD3 or CD3/CD19 depletion and conditioning with fludarabine, cyclophosphamide and antithymocyte globulin for acquired severe aplastic anaemia.
authors: Kyung-Nam
authors: KN
authors: Koh
authors: Ho Joon
authors: HJ
authors: Im
authors: Bo Eun
authors: BE
authors: Kim
authors: Eun Seok
authors: ES
authors: Choi
authors: Seongsoo
authors: S
authors: Jang
authors: Seog Woon
authors: SW
authors: Kwon
authors: Chan-Jeoung
authors: CJ
authors: Park
authors: Jong Jin
authors: JJ
authors: Seo
mesh_terms: D000293:Adolescent; D000328:Adult; D000741:Anemia, Aplastic / Q000401:mortality / Q000628:therapy*; D018941:Antigens, CD19; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017252:CD3 Complex; D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D008212:Lymphocyte Depletion; D008297:Male; D019653:Myeloablative Agonists / Q000008:administration & dosage*; D011446:Prospective Studies; D012720:Severity of Illness Index; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D061349:Unrelated Donors; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: D018941:Antigens, CD19; D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D017252:CD3 Complex; D007155:Immunologic Factors; D019653:Myeloablative Agonists; D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine